1. Home
  2. UBX vs LIQT Comparison

UBX vs LIQT Comparison

Compare UBX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • LIQT
  • Stock Information
  • Founded
  • UBX 2009
  • LIQT 2004
  • Country
  • UBX United States
  • LIQT Denmark
  • Employees
  • UBX N/A
  • LIQT N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • UBX Health Care
  • LIQT Technology
  • Exchange
  • UBX Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • UBX 18.4M
  • LIQT 16.9M
  • IPO Year
  • UBX 2018
  • LIQT N/A
  • Fundamental
  • Price
  • UBX $0.75
  • LIQT $1.50
  • Analyst Decision
  • UBX Strong Buy
  • LIQT Strong Buy
  • Analyst Count
  • UBX 3
  • LIQT 2
  • Target Price
  • UBX $5.33
  • LIQT $4.70
  • AVG Volume (30 Days)
  • UBX 141.5K
  • LIQT 5.6K
  • Earning Date
  • UBX 04-22-2025
  • LIQT 05-14-2025
  • Dividend Yield
  • UBX N/A
  • LIQT N/A
  • EPS Growth
  • UBX N/A
  • LIQT N/A
  • EPS
  • UBX N/A
  • LIQT N/A
  • Revenue
  • UBX N/A
  • LIQT $14,604,618.00
  • Revenue This Year
  • UBX N/A
  • LIQT $32.70
  • Revenue Next Year
  • UBX N/A
  • LIQT $15.79
  • P/E Ratio
  • UBX N/A
  • LIQT N/A
  • Revenue Growth
  • UBX N/A
  • LIQT N/A
  • 52 Week Low
  • UBX $0.85
  • LIQT $1.34
  • 52 Week High
  • UBX $3.10
  • LIQT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • UBX 28.49
  • LIQT 51.00
  • Support Level
  • UBX $0.70
  • LIQT $1.48
  • Resistance Level
  • UBX $0.95
  • LIQT $1.60
  • Average True Range (ATR)
  • UBX 0.10
  • LIQT 0.06
  • MACD
  • UBX -0.01
  • LIQT -0.00
  • Stochastic Oscillator
  • UBX 8.49
  • LIQT 54.55

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: